Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 109, 126-138
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- Bioavailability enhancement of glucosamine hydrochloride by chitosanInternational Journal of Pharmaceutics, 2013
- Synthesis and characterization of selenium–chondroitin sulfate nanoparticlesCarbohydrate Polymers, 2012
- Role of glucosamine in the treatment for osteoarthritisRheumatology International, 2012
- l-Carnitine enhances extracellular matrix synthesis in human primary chondrocytesRheumatology International, 2012
- The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes – Implications for osteoarthritisBiochemical and Biophysical Research Communications, 2011
- A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individualsDiabetes/Metabolism Research and Reviews, 2010
- The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combinationOsteoarthritis and Cartilage, 2010
- Chondroitin sulfate for the treatment of hip and knee osteoarthritis: Current status and future trendsLife Sciences, 2009
- The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trialArthritis & Rheumatism, 2008
- Glucosamine Inhibits Inducible Nitric Oxide SynthesisBiochemical and Biophysical Research Communications, 2000